Home / Compliance / AU
Compliance · AU

Therapeutic goods compliance with the TGA

In short

Medicines, medical devices, biologicals and other therapeutic goods supplied in Australia must be entered in the Australian Register of Therapeutic Goods (ARTG) unless exempt. Sponsors and manufacturers have ongoing obligations under the Therapeutic Goods Act 1989 (Cth). This guide covers the 10 core TGA compliance obligations.

Build compliance into your firm — free trial
Who must comply

Coverage

Australian sponsors, manufacturers, importers, wholesalers and retailers of therapeutic goods, including online pharmacies, cosmeceutical companies with therapeutic claims and medical device distributors.

Legal basis

Therapeutic Goods Act 1989 (Cth) and Therapeutic Goods Regulations 1990. Therapeutic Goods (Medical Devices) Regulations 2002. Therapeutic Goods Advertising Code 2021. Uniform Recall Procedure for Therapeutic Goods (URPTG).

10 obligations

The obligations

1

Include goods in the ARTG

Include the therapeutic goods in the ARTG under the correct pathway (listed, assessed listed, registered or included) before supply in Australia, unless an exemption applies.

Therapeutic Goods Act 1989 (Cth) s 19D
2

Meet manufacturing and GMP requirements

Manufacture goods in facilities that hold a TGA manufacturing licence (or acceptable overseas certification) and comply with Good Manufacturing Practice.

Therapeutic Goods Act 1989 (Cth) Part 3-3
3

Comply with the Essential Principles for devices

Medical devices must meet the Essential Principles for safety and performance, with appropriate conformity assessment evidence for their class.

Therapeutic Goods (Medical Devices) Regulations 2002 sch 1
4

Follow the Therapeutic Goods Advertising Code

Advertising to consumers must comply with the Advertising Code, avoid prohibited representations and not promote Schedule 4 or 8 medicines.

Therapeutic Goods Act 1989 (Cth) Part 5-1; Advertising Code 2021
5

Report adverse events

Sponsors must report serious adverse events and problems within the mandated timeframes, including via the Database of Adverse Event Notifications.

Therapeutic Goods Act 1989 (Cth) ss 29A–29AA
6

Comply with labelling and packaging rules

Label and package goods in accordance with TGO 91, TGO 92 and device labelling requirements, including active ingredients, warnings and storage conditions.

Therapeutic Goods Orders 91 and 92; Therapeutic Goods (Medical Devices) Regulations 2002
7

Honour post-market surveillance obligations

Implement post-market surveillance plans, periodic reviews and unique device identifier expectations where the device class or TGA conditions require it.

Therapeutic Goods Act 1989 (Cth) s 41MP
8

Manage recalls under URPTG

Notify the TGA and coordinate recalls, hazard alerts and safety advisory notices under the Uniform Recall Procedure for Therapeutic Goods.

Therapeutic Goods Act 1989 (Cth) s 30EA; URPTG
9

Keep records and respond to TGA inspections

Keep batch, distribution, complaint and advertising records, and allow TGA inspections and information-gathering notices under the Act.

Therapeutic Goods Act 1989 (Cth) Part 6-2
10

Use the TGA Business Services portal

Use the TBS portal for ARTG entries, annual charges, variations and cancellations, and pay annual and low-value turnover charges when required.

Therapeutic Goods (Charges) Act 1989 (Cth)
Penalties

What happens if you do not comply

The Therapeutic Goods Act 1989 (Cth) provides for civil penalties up to approximately $1.565 million per contravention for individuals and $15.65 million for corporations, plus criminal offences for unlawful supply, advertising and non-compliance with recalls.

Reporting requirements

Sponsors and manufacturers must submit adverse event reports, annual entry maintenance, variation notifications, recall notifications, and periodic safety updates required by TGA conditions.

Practical steps

What firms should do today

  • Maintain a product-by-product ARTG and conformity assessment dossier
  • Run a quarterly advertising compliance check aligned with the Advertising Code
  • Keep adverse event reporting SLAs aligned with statutory timeframes
  • Rehearse URPTG recalls with distributors at least annually
  • Monitor TGA safety signals and guidance updates monthly
Use with Quillio

Compliance with Quillio

Quillio reviews supply, distribution and advertising agreements to align sponsor obligations, indemnities and recall triggers with the Therapeutic Goods Act and Advertising Code. See /resources/security.

This guide is general information about therapeutic goods compliance in Australia — not legal or regulatory advice. Sponsors should work with a specialist regulatory lawyer and TGA consultant.

Build compliance into your stack.

Quillio is built around AU compliance from the ground up — SOC 2 Type II + ISO 27001 + Australian data sovereignty. The free trial requires no credit card.

Start your free trial